Recombinant adeno-associated virus transduction and integration

Brian R Schultz1, Jeffrey S Chamberlain

  • 1Molecular and Cellular Biology, Senator Paul D Wellstone Muscular Dystrophy Cooperative Research Center, University of Washington, Seattle, Washington, USA.

Summary

Recombinant adeno-associated virus (rAAV) gene therapy shows promise for genetic disorders. Understanding rAAV transduction pathways is key for effective treatment, as multiple mechanisms influence transgene expression based on serotype, dose, and cell type.

Related Concept Videos